NL-OMON49420
Not yet recruiting
Phase 2
Transcutaneous vagus nerve stimulation to enhance exposure efficacy in public speaking anxiety - tvNS and exposure for public speaking anxiety
niversiteit Leiden0 sites52 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversiteit Leiden
- Enrollment
- 52
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A. Between 18\-70 years old
- •B. Social Anxiety Disorder (SAD) as established with a structured interview
- •(MINI), and with speech anxiety as primary fear
- •C. Self reported SAD symptoms above clinical cut\-off (score \> 30 on the LSAS).
Exclusion Criteria
- •A. Prior non response to exposure therapy (i.c. speech exposure) for SAD
- •symptoms, as defined by the patient\*s report of receiving specific and regular
- •exposure assignments as part of previous therapy.
- •B. Prior participation in tVNS research
- •C. Entry of patients with other mood or anxiety disorders will be permitted in
- •order to increase accrual of a clinically relevant sample; however in cases
- •where SAD is not judged to be the predominant disorder, participants will not
- •be eligible.
- •D. Psychosis or delusion disorders (current or in the past)
- •E. Patients with significant suicidal ideations or who have enacted suicidal
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Transcutaneous vagus nerve stimulation to enhance exposure efficacy in public speaking anxietyNL-OMON20935eiden University Behandel en Expertise Centrum52
Not yet recruiting
Not Applicable
Transcutaneous vagal nerve stimulation to improve cognitive control in patients with Parkinson’s diseaseG20Parkinson diseaseDRKS00025548niversitätsklinik für Neurologie, Evangelisches Krankenhaus Oldenburg Neurologie, Fakultät für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg26
Completed
Not Applicable
Transcutaneous Vagus Nerve Stimulation for the treatment of chronic migraineG43.3Complicated migraineDRKS00003681cerbomed GmbH46
Not yet recruiting
Not Applicable
A role of transcutaneous vagus nerve stimulation on left ventricular function and afterload in Takotsubo syndromeJPRN-UMIN000051017Hiroshima City Asa Hospital6
Recruiting
Not Applicable
The role of transcutaneous vagus nerve stimulation in post-error slowinghet onderzoek is van algemeen cognitief-psychologische aard en heeft geen betrekking op stoornissen of aandoeningen.not applicableNL-OMON41900niversiteit Leiden48